Business Wire (Wed, 4-Feb 8:15 AM ET)
TipRanks (Tue, 3-Feb 5:20 AM ET)
Neutral on Hologic Amid Take-Private Overhang and Brevera-Driven CVR Risk
TipRanks (Sun, 1-Feb 10:25 AM ET)
Hologic Announces Financial Results for First Quarter of Fiscal 2026
Business Wire (Thu, 29-Jan 4:02 PM ET)
Globe Newswire (Sat, 17-Jan 1:00 PM ET)
Business Wire (Thu, 15-Jan 7:00 PM ET)
Business Wire (Tue, 13-Jan 9:00 AM ET)
PRNewswire (Thu, 8-Jan 11:51 AM ET)
PRNewswire (Wed, 7-Jan 5:13 PM ET)
PRNewswire (Tue, 23-Dec 6:56 PM ET)
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Hologic trades on the NASDAQ stock market under the symbol HOLX.
As of February 5, 2026, HOLX stock price climbed to $74.70 with 3,294,795 million shares trading.
HOLX has a beta of 0.11, meaning it tends to be less sensitive to market movements. HOLX has a correlation of 0.01 to the broad based SPY ETF.
HOLX has a market cap of $16.68 billion. This is considered a Large Cap stock.
Last quarter Hologic reported $1 billion in Revenue and $1.04 earnings per share. This fell short of revenue expectation by $-24 million and missed earnings estimates by -$.06.
In the last 3 years, HOLX traded as high as $87.88 and as low as $51.90.
The top ETF exchange traded funds that HOLX belongs to (by Net Assets): VTI, VOO, VB, VBR, IVV.
HOLX has underperformed the market in the last year with a return of +4.4%, while SPY returned +13.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HOLX shares. However, HOLX has outperformed the market in the last 3 month and 2 week periods, returning +0.8% and -0.6%, while SPY returned +0.6% and -1.1%, respectively. This indicates HOLX has been having a stronger performance recently.
HOLX support price is $74.18 and resistance is $75.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HOLX shares will trade within this expected range on the day.